These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 16735528)
1. Efficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomes. Gartlehner G; Hansen RA; Carson SS; Lohr KN Ann Fam Med; 2006; 4(3):253-62. PubMed ID: 16735528 [TBL] [Abstract][Full Text] [Related]
2. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT. Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402 [TBL] [Abstract][Full Text] [Related]
6. The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials. Alsaeedi A; Sin DD; McAlister FA Am J Med; 2002 Jul; 113(1):59-65. PubMed ID: 12106623 [TBL] [Abstract][Full Text] [Related]
7. Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease. van Geffen WH; Tan DJ; Walters JA; Walters EH Cochrane Database Syst Rev; 2023 Dec; 12(12):CD011600. PubMed ID: 38054551 [TBL] [Abstract][Full Text] [Related]
8. Management of stable chronic obstructive pulmonary disease: a systematic review for a clinical practice guideline. Wilt TJ; Niewoehner D; MacDonald R; Kane RL Ann Intern Med; 2007 Nov; 147(9):639-53. PubMed ID: 17975187 [TBL] [Abstract][Full Text] [Related]
10. Effect of Theophylline as Adjunct to Inhaled Corticosteroids on Exacerbations in Patients With COPD: A Randomized Clinical Trial. Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; De Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D JAMA; 2018 Oct; 320(15):1548-1559. PubMed ID: 30326124 [TBL] [Abstract][Full Text] [Related]
11. Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis. Kew KM; Dias S; Cates CJ Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD010844. PubMed ID: 24671923 [TBL] [Abstract][Full Text] [Related]
12. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma. Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410 [TBL] [Abstract][Full Text] [Related]
13. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD. Hanania NA Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761 [TBL] [Abstract][Full Text] [Related]
14. Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease. Nannini LJ; Poole P; Milan SJ; Kesterton A Cochrane Database Syst Rev; 2013 Aug; 2013(8):CD006826. PubMed ID: 23990350 [TBL] [Abstract][Full Text] [Related]
16. Addition of anti-leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma. Chauhan BF; Jeyaraman MM; Singh Mann A; Lys J; Abou-Setta AM; Zarychanski R; Ducharme FM Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010347. PubMed ID: 28301050 [TBL] [Abstract][Full Text] [Related]
17. Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease. Maqsood U; Ho TN; Palmer K; Eccles FJ; Munavvar M; Wang R; Crossingham I; Evans DJ Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012930. PubMed ID: 30839102 [TBL] [Abstract][Full Text] [Related]